GLP-1 & incretin therapies · Live ClinicalTrials.gov data

Survodutide clinical trial pipeline

ClinicalTrials.gov lists 15 phase 2–4 trials for survodutide, 3 of them actively recruiting. The next phase 3 primary completion among them is expected Jan 2028. Refreshed daily. Add up to four competitors to compare pipelines side by side.

15

Phase 2–4 trials

12

Phase 3 trials

3

Actively recruiting

Jan 2028

Next phase 3 primary completion

14,153

Participants across trials

Boehringer Ingelheim

Lead sponsor by trial count

survodutide (15)7 active2021–2033
survodutide
Key
Actual date
Anticipated
Forecast to primary completion
RecruitingNot yet recruitingCompleted
'21
'22
'23
'24
'25
'26
'27
'28
'29
'30
'31
'32
'33
survodutide
A Study to Test Whether Different Doses of BI 456906 Help People With Overweight or Obesity to Lose WeightP2
A Study to Test Safety and Efficacy of Survodutide (BI456906) in Adults With Non-alcoholic Steatohepatitis (NASH) and Fibrosis (F1-F3)P2
A Study to Test the Effect of Survodutide (BI 456906) on Cardiovascular Safety in People With Overweight or Obesity (SYNCHRONIZE™ - CVOT)P3
SYNCHRONIZE™-1P3
SYNCHRONIZE™-2P3
SYNCHRONIZE™JPP3
A Study to Test Whether Survodutide (BI 456906) Helps Chinese People Living With Overweight or Obesity to Lose WeightP3
A Study to Test Whether Survodutide Helps People Living With Obesity or Overweight and With a Confirmed or Presumed Liver Disease Called Non-alcoholic Steatohepatitis (NASH) to Reduce Liver Fat and to Lose Weight (SYNCHRONIZE-MASLD)P3
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver FibrosisP3
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have CirrhosisP3
ARTIST-CKDP2
A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood SugarP3
ELEVATE-LIVER: A Study to Test Whether Survodutide Helps Improve Heart Structure and Function in People With Overweight or Obesity and Fatty Liver DiseaseP3
SYNCHRONIZE®-HERA: A Study to Test Whether Survodutide Helps Women Who Are Living With Overweight or Obesity and Are Going Through or Have Finished Menopause, to Lose WeightP3
SYNCHRONIZE®-START- A Study to Test Whether Survodutide Helps People Living With Overweight or Obesity Who do Not Have Diabetes to Lose WeightP3

Upcoming readouts

7 ahead · survodutide

Select a trial to load its full ClinicalTrials.gov record.

Key survodutide trials

Top 12 of the 15 registered phase 2–4 trials, ordered by phase and status. Trial names open the full ComplyRx trial page; NCT ids link to ClinicalTrials.gov.

TrialTitlePhaseStatusPrimary completion
NCT07754461A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood SugarPhase 3RecruitingJan 2028
NCT06632457LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Cal…Phase 3RecruitingJun 2029
NCT06632444LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MAS…Phase 3RecruitingDec 2031
NCT07855900SYNCHRONIZE®-START- A Study to Test Whether Survodutide Helps People Living With Overweight or O…Phase 3Not yet recruitingJun 2028
NCT07850050SYNCHRONIZE®-HERA: A Study to Test Whether Survodutide Helps Women Who Are Living With Overweigh…Phase 3Not yet recruitingJul 2028
NCT07850063ELEVATE-LIVER: A Study to Test Whether Survodutide Helps Improve Heart Structure and Function in…Phase 3Not yet recruitingApr 2029
NCT06214741A Study to Test Whether Survodutide (BI 456906) Helps Chinese People Living With Overweight or O…Phase 3CompletedJul 2025
NCT06309992A Study to Test Whether Survodutide Helps People Living With Obesity or Overweight and With a Co…Phase 3CompletedOct 2025
NCT06066515SYNCHRONIZE™-1: A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity W…Phase 3CompletedDec 2025
NCT06176365SYNCHRONIZE™JP: A Study to Test Whether Survodutide Helps Japanese People Living With Obesity DiseasePhase 3CompletedDec 2025
NCT06066528SYNCHRONIZE™-2: A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity W…Phase 3CompletedDec 2025
NCT06077864A Study to Test the Effect of Survodutide (BI 456906) on Cardiovascular Safety in People With Ov…Phase 3CompletedJun 2026

Track survodutide with ComplyRx

Get an alert when a trial changes status, moves its completion date, or a new trial registers in scope. Checked nightly against ClinicalTrials.gov.

Track survodutide

FAQ

How many clinical trials are running for survodutide?
ClinicalTrials.gov currently lists 15 phase 2–4 survodutide trials: 3 phase 2, 12 phase 3, and 0 phase 4. 3 are actively recruiting.
Where does this data come from?
All trial data is sourced from ClinicalTrials.gov (CTGov) and refreshed on this page daily.
Can I compare survodutide against other drugs?
Yes. The free ComplyRx Trial Pipeline tool compares up to five drugs side by side on one timeline, with PNG and PDF export. Add any competitor in the search box above.

Keep following
what matters.

Choose the drugs, companies or disease areas you follow. Bring trial changes and upcoming readouts into one watch.

Build your watch

Choose what to track in the watch builder.